Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

283.39
-1.3100-0.46%
Volume:111.25K
Turnover:31.52M
Market Cap:5.65B
PE:29.19
High:285.64
Open:285.63
Low:280.49
Close:284.70
52wk High:326.63
52wk Low:163.45
Shares:19.94M
Float Shares:19.35M
Volume Ratio:0.50
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.84
PE(LYR):46.23

Loading ...

May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 19, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]